Expansion of Lonza’s Automated Robotic Solution for Endotoxin Testing Automates Sustainable Recombinant Factor C Assay

12 Apr 2021 Downloads News Release PDF The PyroTec® PRO Automated Solution combined with the PyroWave® Reader option expands the range of endotoxin testing types available on the platform to now include the PyroGene® Recombinant Factor C assay The addition of the PyroWave® XM Fluorescent Reader complements the existing absorbance readers used in traditional LAL-based assays Full integration with... Read more

FDA Authorizes New High-Throughput, Automated System for Leading COVID-19 Test

The Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit enables laboratories to rapidly scale high-sensitivity PCR testing capacity as schools and employers seek increased testing to support reopening strategies WALTHAM, Mass., April 12, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that the U.S. Food and Drug... Read more

Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess

Abby is the next generation chemiluminescence Western protein analyzer and Stellar modules set the standard for fluorescence sensitivity MINNEAPOLIS, April 8, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that ProteinSimple, a Bio-Techne brand, released Abby, its next generation chemiluminescence system that automates traditional Western blotting.  This latest addition to the Simple Western product family offers... Read more

New Roche data at 2021 AAN highlight impact and breadth of expanding neuroscience portfolio

EVRYSDI 2-year FIREFISH Part 2 data show improvement in motor function in infants with Type 1 spinal muscular atrophy (SMA) OCREVUS data show its consistent benefit on slowing disease progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS) Data for ENSPRYNG in neuromyelitis optica spectrum disorder (NMOSD) reinforce safety and efficacy, including in... Read more

Brooks Life Sciences and GENEWIZ to host 2-day virtual event focused on cell and gene therapy April 7-8, 2021

Brooks Life Sciences and GENEWIZ to host 2-day virtual event focused on cell and gene therapy April 7-8, 2021 Highlighted speakers from 10x Genomics, AskBio, Kuopio Center for Gene and Cell Therapy, Pacific Biosciences, and Pluristyx SOUTH PLAINFIELD, N.J., April 6, 2021 /PRNewswire/ — The Advancing CGT Virtual Event presented by GENEWIZ and Brooks Life... Read more

BUCHI optimizes safety and durability of industrial evaporation with new 50 L Rotavapor R-250 Pro

06.04.2021 Flawil, Switzerland, 06.04.2021 – With the launch of the Rotavapor® R-250 Pro, BÜCHI Labortechnik AG introduces an update of the industrial evaporation unit with the capacity of a 50-liter evaporation flask. The new system offers a unique operating concept, the proverbial high BUCHI quality, many safety features and a robust design to improve demanding workflows... Read more

10x Genomics Puts Single Cell Analysis Within Reach of All With Low Throughput Gene Expression Kit

April 1, 2021 at 8:30 AM EDTPDF Version Along with recent release of CellPlex, product increases access through affordability PLEASANTON, Calif., April 01, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced the launch of its Chromium Single Cell Gene Expression Low Throughput (LT) Kit, a new offering designed to put the power of... Read more

Thermo Fisher Scientific Announces New System for Flexible, Automated Sample Purification

Thermo Fisher Scientific Announces New System for Flexible, Automated Sample Purification KingFisher Apex Purification System isolates nucleic acids, proteins and cells with customizable protocols CARLSBAD, Calif., April 1, 2021 /PRNewswire/ — Thermo Fisher Scientific today launched the Thermo Scientific KingFisher Apex Purification System, a high-throughput sample purification instrument designed for scientists who need to automate the... Read more

EUROIMMUN Launches SARS-CoV-2 NeutraLISA Assay to Determine the Neutralizing Capacity of Anti-SARS-CoV-2 Antibodies

CE marked assay based on well-established ELISA technology expands EUROIMMUN’s offerings for labs that seek to understand immune response to COVID-19 WALTHAM, Mass. – April 1, 2021 – EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the SARS-CoV-2 NeutraLISATM assay, a surrogate neutralization test intended for the detection of neutralizing antibodies against SARS-CoV-2,... Read more